Colares Neto Guido de Paula, Ide Yamauchi Fernando, Hueb Baroni Ronaldo, de Andrade Bianchi Marco, Cavalanti Gomes Andrea, Chammas Maria Cristina, Matsunaga Martin Regina
Department of Internal Medicine, Division of Endocrinology, Osteometabolic Disorders Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Department of Internal Medicine, Division of Endocrinology, Laboratório de Hormônios e Genética Molecular (LIM/42), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
J Endocr Soc. 2019 Mar 25;3(5):1053-1061. doi: 10.1210/js.2018-00338. eCollection 2019 May 1.
Nephrocalcinosis (NC) and nephrolithiasis (NL) are described in hypophosphatemic rickets, but data regarding their prevalence rates and the presence of metabolic risk factors in X-linked hypophosphatemic rickets (XLH) are scarce.
To determine the prevalence rates of NC and NL and their risk factors in patients with XLH with confirmed mutations.
Renal ultrasonography (US) and CT were performed in 16 children and 23 adults. The images were evaluated by two blinded radiologists specializing in US and two specializing in CT. Confirmation of NC was determined with a positive result on both US and CT, whereas the diagnosis of NL was confirmed by CT alone. The presence of hypercalciuria, hypocitraturia, and hyperoxaluria was determined from 24-hour urinary samples from each patient. The glomerular filtration rate was estimated.
NC was identified in 15 patients (38.4%), and stratification by age group showed a higher prevalence of NC in children than in adults (56.2% vs 26.1%). CT identified NL in four adults (10.2%). Patients in the pediatric group required intensive use of phosphate, started treatment earlier, and presented greater phosphaturia than those in the adult group ( < 0.01). In addition to hyperphosphaturia, which was present in all patients with XLH, hypocitraturia was the most common metabolic factor (28.2%), whereas hypercalciuria occurred in two patients (5.1%). None had hyperoxaluria. Most patients had normal renal function.
NC was more prevalent than NL. The main metabolic factor was hyperphosphaturia, and intensive phosphate treatment appears to be a worsening factor for kidney calcification.
低磷性佝偻病中存在肾钙质沉着症(NC)和肾结石(NL),但关于X连锁低磷性佝偻病(XLH)中它们的患病率以及代谢危险因素的数据稀缺。
确定确诊有突变的XLH患者中NC和NL的患病率及其危险因素。
对16名儿童和23名成人进行肾脏超声检查(US)和CT检查。图像由两名专门从事超声检查的盲法放射科医生和两名专门从事CT检查的医生进行评估。NC的确诊需US和CT结果均为阳性,而NL的诊断仅通过CT确诊。从每位患者的24小时尿液样本中测定高钙尿症、低枸橼酸尿症和高草酸尿症的存在情况。估算肾小球滤过率。
15名患者(38.4%)被诊断为NC,按年龄组分层显示儿童中NC的患病率高于成人(56.2%对26.1%)。CT在4名成人(10.2%)中发现了NL。儿科组患者比成人组更频繁地大量使用磷酸盐,更早开始治疗,且表现出更大的磷尿症(<0.01)。除了所有XLH患者均存在的高磷尿症外,低枸橼酸尿症是最常见的代谢因素(28.2%),而两名患者(5.1%)出现高钙尿症。无人有高草酸尿症。大多数患者肾功能正常。
NC比NL更常见。主要代谢因素是高磷尿症,强化磷酸盐治疗似乎是肾脏钙化的一个恶化因素。